Model structures of alpha-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands.
about
Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigationStructure and dynamics of DRD4 bound to an agonist and an antagonist using in silico approaches.CoMFA analyses of C-2 position salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity.Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptorsModeling of the OX1R-orexin-A complex suggests two alternative binding modes.The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analoguesInvolvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.
P2860
Q24599290-A79BEB54-EF23-4629-AB3E-193E131955CDQ30009287-CCB3DE33-D631-4680-BE77-F5C5D0871722Q33808544-AA1E61E2-282F-43BF-AACD-59D7949EF85BQ33893723-BB0F09DB-FA45-49DC-9B9C-5EA38A861FA8Q34737074-6CBE9085-6BE6-4966-AFCF-3F758914F789Q35048522-27BFF16F-1E74-4555-9430-383766D93C89Q35625908-C6AFC63A-FE78-4C51-AA67-B41EE3719100Q36358116-C8FF31FF-724A-4B4C-9D39-E165E435E6A7Q39264759-3D9C23FF-8BD8-4B6F-9260-219A33C9B560Q42727402-D23EB0C0-22A1-4530-8C86-ECBE4C1DFD82Q52684757-DEEF5C26-51C9-48C3-B4D1-B0409C7B6E04
P2860
Model structures of alpha-2 adrenoceptors in complex with automatically docked antagonist ligands raise the possibility of interactions dissimilar from agonist ligands.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@ast
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@en
type
label
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@ast
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@en
prefLabel
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@ast
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@en
P2093
P1476
Model structures of alpha-2 ad ...... ssimilar from agonist ligands.
@en
P2093
Henri Xhaard
Jonne Laurila
Jori O Ruuskanen
Mark S Johnson
Mika Scheinin
Ville-Veikko Rantanen
P304
P356
10.1016/J.JSB.2004.12.008
P577
2005-05-01T00:00:00Z